Clinical Trials for CG Oncology

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CG Oncology

Clinical Trials (4)

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

PHASE2Recruiting

325 participants

Started: Sep 16, 2024 · Completed: Dec 30, 2027

1 condition1 sponsor58 locations

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

PHASE3Active, not recruiting

367 participants

Started: Dec 14, 2023 · Completed: Jan 31, 2030

4 conditions1 sponsor95 locations

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

PHASE3Active, not recruiting

190 participants

Started: Oct 27, 2020 · Completed: Dec 24, 2029

2 conditions1 sponsor72 locations

Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

PHASE1Active, not recruiting

21 participants

Started: Oct 26, 2020 · Completed: Jan 31, 2026

2 conditions3 sponsors1 location